Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDR | P35968 | 2/20 | 0.68 |
| ▸ | CHEK1 | O14757 | 1/20 | 0.68 |
| ▸ | CDK5 | Q00535 | 6/20 | 0.61 |
| ▸ | CDK5R1 | Q15078 | 6/20 | 0.61 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.58 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.58 |
| ▸ | BRD4 | O60885 | 1/20 | 0.56 |
| ▸ | DAO | P14920 | 1/20 | 0.56 |
| ▸ | DDO | Q99489 | 1/20 | 0.56 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.55 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.55 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.55 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.55 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.55 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.55 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.55 |
| ▸ | NPC1 | O15118 | 3/20 | 0.55 |
| ▸ | RAB9A | P51151 | 3/20 | 0.55 |
| ▸ | MEN1 | O00255 | 1/20 | 0.54 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29712353 | 1.00 | KDR (0.68) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL8481746 | 0.89 | KDR (0.59) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL30740090 | 0.86 | KDM4E (0.60) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL5543795 | 0.86 | KDR (0.60) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL29206326 | 0.86 | BRD4 (0.64) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL11178624 | 0.86 | KDM4E (0.60) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL30740091 | 0.86 | KDR (0.60) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL11347026 | 0.86 | CDK5 (0.65) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL3963947 | 0.86 | CDK5 (0.68) | KDRCHEK1CDK5CDK5R1PDGFRB | |
| SCHEMBL29206332 | 0.85 | KDR (0.55) | KDRCHEK1CDK5CDK5R1PDGFRB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 182 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4644376-A1 | NEW PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTI-CANCER FUNCTIONS AND PREPARATION THEREOF | Alphamol Science Ltd (Shanghai) (CN) | 2025-11-05 | — | — | EP | claimed |
| EP-4644391-A1 | NOVEL PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTICANCER FUNCTIONS, AND PREPARATION THEREOF | Alphamol Science Ltd (Shanghai) (CN) | 2025-11-05 | — | — | EP | claimed |
| WO-2024138292-A1 | NOVEL PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTICANCER FUNCTIONS, AND PREPARATION THEREOF | 深圳阿尔法分子科技有限责任公司 | 2024-07-04 | — | — | WO | claimed |
| WO-2024141126-A1 | NEW PHENYLQUINOLONE COMPOUND HAVING ANTIBACTERIAL AND ANTI-CANCER FUNCTIONS AND PREPARATION THEREOF | 深圳阿尔法分子科技有限责任公司 | 2024-07-04 | — | — | WO | claimed |
| CN-118255716-A | Novel phenyl quinolone compound with antibacterial and anticancer functions and preparation thereof | 深圳阿尔法分子科技有限责任公司 | 2024-06-28 | — | — | CN | claimed |
| EP-4046638-A1 | USE OF PHENYLQUINOLINONES AND FLAVONOID DERIVATIVES FOR TREATING NEUROPATHIC PAIN | Hangzhou Bio-Sincerity Pharma-tech Co., Ltd. (CN) | 2022-08-24 | — | — | EP | claimed |
| EP-2686438-B1 | A METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFOR | VENTANA MED SYST INC (US) | 2018-04-18 | — | — | EP | claimed |
| US-9562259-B2 | Method of analyzing chromosomal inversions | VENTANA MEDICAL SYSTEMS, INC. (US) | 2017-02-07 | — | — | US | claimed |
| EP-2686438-A1 | A METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFORE | Ventana Medical Systems, Inc. (US) | 2014-01-22 | — | — | EP | claimed |
| EP-2539355-A1 | POLYTAG PROBES | Ventana Medical Systems, Inc. (US) | 2013-01-02 | — | — | EP | claimed |
| EP-2539466-A1 | CYTOGENIC ANALYSIS OF METAPHASE CHROMOSOMES | Ventana Medical Systems, Inc. (US) | 2013-01-02 | — | — | EP | claimed |
| US-20120301885-A1 | CYTOGENIC ANALYSIS OF METAPHASE CHROMOSOMES | TANG LEI (US) | 2012-11-29 | — | — | US | claimed |
| US-20120301886-A1 | POLYTAG PROBES | VENTANA MEDICAL SYSTEMS, INC. | 2012-11-29 | — | — | US | claimed |
| US-20120237930-A1 | METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFORE | VENTANA MEDICAL SYSTEMS, INC. | 2012-09-20 | — | — | US | claimed |
| WO-2012123387-A1 | A METHOD OF ANALYZING CHROMOSOMAL TRANSLOCATIONS AND A SYSTEM THEREFORE | F. HOFFMANN-LA ROCHE AG (CH) | 2012-09-20 | — | — | WO | claimed |
| EP-0073875-B1 | AZO DYESTUFFS, PROCESS FOR THEIR PREPARATION AND THEIR USE | CASSELLA Aktiengesellschaft (DE) | 1988-09-07 | — | — | EP | claimed |
| JP-3024047-A | — | — | None | — | — | JP | disclosed |
| US-12587724-B2 | Digitally enhanced microscopy for multiplexed histology | VENTANA MEDICAL SYSTEMS, INC. (US) | 2026-03-24 | — | — | US | disclosed |
| US-4008086-A | PYRIDONE OR PYRIDAZONE DERIVATIVES | KONISHIROKU PHOTO INDUSTRY CO., LTD. (JA) | 1977-02-15 | — | — | US | disclosed |
| US-4006148-A | Carbostyril derivatives used as coccidiostats | IMC CHEMICAL GROUP, INC. (US) | 1977-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12587724-B2 | Digitally enhanced microscopy for multiplexed histology | MAP1LC3B, MAP1LC3A, MAP1LC3C | KDR 506/4885CHEK1 1265/4885CDK5 1657/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.